Pacific Shuanglin Bio-Pharmacy Co., Ltd is a publicly listed company located in Zhanjiang. The company specializes in the research, development, production, and sale of blood bioproducts and health recovery products. Their main products include human albumin, human immunoglobulin, and intravenous immunoglobulin. As the company continues to expand its industrial scale and extend its supply chain, both the product structure and customer structure have been optimized. The company has also made progress in project research and development, product testing, and sales strategies. In the future, the company aims to improve the comprehensive management level of plasma stations, strengthen the development and research of comprehensive plasma utilization, and enhance product quality by adhering to the requirements of the new version of GMP regulations. The company aims to maintain a good reputation for its products in the industry. On November 15, 2019, the company changed its name from "Zhenxing Biochemical Co., Ltd." to "Southern Shuanglin Bio-Pharmacy Co., Ltd." On April 2, 2021, the company changed its name again to "Pacific Shuanglin Bio-Pharmacy Co., Ltd."
Headquarters
No. 1, Xinfeng East Road, Donghai Island, Dongjian Town, Mazhang District, Zhanjiang City, Guangdong Province
Shanghai; Shanghai;
Postal Code: 201100
Contact Details: Purchase the Pacific Shuanglin Bio-Pharmacy Co., Ltd report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service